This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer recognition
Customer-specific caching
Individual prices
PayPal payments
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Statistics & Tracking
Affiliate program
Track device being used
ACCURUN 305 Series 400 HCV RNA Control
ACCURUN 305 Series 400 HCV RNA Control
#2020-0085 / #A305-6432Positive Control is for use with in vitro assays for the detection and quantification of HCV RNA.
ACCURUN 305 Series 400 HCV RNA positive control is formulated for use with in vitro assay procedures that detect and quantitate HCV RNA. ACCURUN 305 Series 100 is manufactured from human serum or plasma, reactive for HCV RNA type 1 and non-reactive for HBsAg and antibodies to HIV 1, HIV 2 and HTLV. ACCURUN 305 can help you avoid costly repeats and, more importantly, false negative or positive results by allowing you to monitor your HCV RNA assay with a reliable source of positive material. Made from naturally occurring plasma or serum; closely resembles an actual patient sample. Nonreactive for HBsAg and antibodies to HIV 1/2, and HTLV. Analytes included: HCV RNA. Regulatory Status: IVD, CE, HC. Reference number: A305-6124
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the usability of this website, serve for direct advertising or simplify interaction with other websites and social networks, will only be used with your consent.